Chapter/Section Purchase

Leave This Empty:

Narcotic (Opioid) Drugs Market, Global Outlook and Forecast 2022-2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Narcotic (Opioid) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Narcotic (Opioid) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Narcotic (Opioid) Drugs Overall Market Size
2.1 Global Narcotic (Opioid) Drugs Market Size: 2021 VS 2028
2.2 Global Narcotic (Opioid) Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Narcotic (Opioid) Drugs Players in Global Market
3.2 Top Global Narcotic (Opioid) Drugs Companies Ranked by Revenue
3.3 Global Narcotic (Opioid) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Narcotic (Opioid) Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Narcotic (Opioid) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Narcotic (Opioid) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Narcotic (Opioid) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Narcotic (Opioid) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Narcotic (Opioid) Drugs Market Size Markets, 2021 & 2028
4.1.2 Codeine
4.1.3 Fentanyl
4.1.4 Hydrocodone
4.1.5 Hydromorphone
4.1.6 Meperidine
4.1.7 Methadone
4.1.8 Others
4.2 By Type - Global Narcotic (Opioid) Drugs Revenue & Forecasts
4.2.1 By Type - Global Narcotic (Opioid) Drugs Revenue, 2017-2022
4.2.2 By Type - Global Narcotic (Opioid) Drugs Revenue, 2023-2028
4.2.3 By Type - Global Narcotic (Opioid) Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Narcotic (Opioid) Drugs Market Size, 2021 & 2028
5.1.2 Pain Relief Application
5.1.3 Anesthesia Application
5.2 By Application - Global Narcotic (Opioid) Drugs Revenue & Forecasts
5.2.1 By Application - Global Narcotic (Opioid) Drugs Revenue, 2017-2022
5.2.2 By Application - Global Narcotic (Opioid) Drugs Revenue, 2023-2028
5.2.3 By Application - Global Narcotic (Opioid) Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Narcotic (Opioid) Drugs Market Size, 2021 & 2028
6.2 By Region - Global Narcotic (Opioid) Drugs Revenue & Forecasts
6.2.1 By Region - Global Narcotic (Opioid) Drugs Revenue, 2017-2022
6.2.2 By Region - Global Narcotic (Opioid) Drugs Revenue, 2023-2028
6.2.3 By Region - Global Narcotic (Opioid) Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Narcotic (Opioid) Drugs Revenue, 2017-2028
6.3.2 US Narcotic (Opioid) Drugs Market Size, 2017-2028
6.3.3 Canada Narcotic (Opioid) Drugs Market Size, 2017-2028
6.3.4 Mexico Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Narcotic (Opioid) Drugs Revenue, 2017-2028
6.4.2 Germany Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.3 France Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.4 U.K. Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.5 Italy Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.6 Russia Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Narcotic (Opioid) Drugs Market Size, 2017-2028
6.4.8 Benelux Narcotic (Opioid) Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Narcotic (Opioid) Drugs Revenue, 2017-2028
6.5.2 China Narcotic (Opioid) Drugs Market Size, 2017-2028
6.5.3 Japan Narcotic (Opioid) Drugs Market Size, 2017-2028
6.5.4 South Korea Narcotic (Opioid) Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Narcotic (Opioid) Drugs Market Size, 2017-2028
6.5.6 India Narcotic (Opioid) Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Narcotic (Opioid) Drugs Revenue, 2017-2028
6.6.2 Brazil Narcotic (Opioid) Drugs Market Size, 2017-2028
6.6.3 Argentina Narcotic (Opioid) Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Narcotic (Opioid) Drugs Revenue, 2017-2028
6.7.2 Turkey Narcotic (Opioid) Drugs Market Size, 2017-2028
6.7.3 Israel Narcotic (Opioid) Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Narcotic (Opioid) Drugs Market Size, 2017-2028
6.7.5 UAE Narcotic (Opioid) Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Narcotic (Opioid) Drugs Major Product Offerings
7.1.4 Pfizer Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Narcotic (Opioid) Drugs Major Product Offerings
7.2.4 Teva Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 Purdue Pharma
7.3.1 Purdue Pharma Corporate Summary
7.3.2 Purdue Pharma Business Overview
7.3.3 Purdue Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.3.5 Purdue Pharma Key News
7.4 Mallinckrodt
7.4.1 Mallinckrodt Corporate Summary
7.4.2 Mallinckrodt Business Overview
7.4.3 Mallinckrodt Narcotic (Opioid) Drugs Major Product Offerings
7.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.4.5 Mallinckrodt Key News
7.5 Amneal Pharma
7.5.1 Amneal Pharma Corporate Summary
7.5.2 Amneal Pharma Business Overview
7.5.3 Amneal Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.5.5 Amneal Pharma Key News
7.6 Collegium
7.6.1 Collegium Corporate Summary
7.6.2 Collegium Business Overview
7.6.3 Collegium Narcotic (Opioid) Drugs Major Product Offerings
7.6.4 Collegium Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.6.5 Collegium Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Major Product Offerings
7.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.7.5 Johnson & Johnson Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Narcotic (Opioid) Drugs Major Product Offerings
7.8.4 Merck Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.8.5 Merck Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Narcotic (Opioid) Drugs Major Product Offerings
7.9.4 Mylan Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.9.5 Mylan Key News
7.10 Hikma Pharmaceuticals
7.10.1 Hikma Pharmaceuticals Corporate Summary
7.10.2 Hikma Pharmaceuticals Business Overview
7.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Major Product Offerings
7.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.10.5 Hikma Pharmaceuticals Key News
7.11 Sun Pharma
7.11.1 Sun Pharma Corporate Summary
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.11.5 Sun Pharma Key News
7.12 Endo Pharmaceuticals
7.12.1 Endo Pharmaceuticals Corporate Summary
7.12.2 Endo Pharmaceuticals Business Overview
7.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Major Product Offerings
7.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.12.5 Endo Pharmaceuticals Key News
7.13 Allergan
7.13.1 Allergan Corporate Summary
7.13.2 Allergan Business Overview
7.13.3 Allergan Narcotic (Opioid) Drugs Major Product Offerings
7.13.4 Allergan Narcotic (Opioid) Drugs Revenue in Global Market (2017-2022)
7.13.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer